Form 4 for MED MEDIFAST INC
Accepted 2022-01-04 00:00:00 ET · period of report 2021-12-31 · accession 0001104659-22-000895 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-04 | 2021-12-31 | MED | Chard Daniel R | COB, CEO, Dir | F - Tax | $209.43 | -11.5K | 28.3K | -29% | -$2.42M | |
| 2022-01-04 | 2022-01-03 | MED | Chard Daniel R | COB, CEO, Dir | G - Gift | $0.00 | -12.5K | 15.7K | -44% | $0 | |
| I | 2022-01-04 | 2022-01-03 | MED | Chard Daniel R | COB, CEO, Dir | G - Gift | $0.00 | +12.5K | 103.1K | +14% | $0 |
| 2022-01-04 | 2021-12-31 | MED | Chard Daniel R | COB, CEO, Dir | M - OptEx | — | +24.1K | 39.8K | +153% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-31 | F | D | 11,533 | $209.43 | 28,255 | D | — | — | |
| 2 | Common | Common Stock | 2022-01-03 | G | D | 12,539 | $0.00 | 15,716 | D | — | — | |
| 3 | Common | Common Stock | 2022-01-03 | G | A | 12,539 | $0.00 | 103,149 | I | — | — | |
| 4 | Common | Common Stock | 2021-12-31 | M | A | 24,072 | — | 39,788 | D The Dan and Allyson Family Irrevocable Trust | — | — | (F1) 12,036 Performance Stock Units were granted on February 20, 2019, and vested on December 31, 2021 and converted into common stock on a two-for-one basis due to the achievement of certain performance factors. (F3) These shares are directly owned by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee. |